Evidence map›Paper›PMID 24347983›Full record

ArticleJournal of pharmacology & pharmacotherapeutics2013

A questionnaire-based study in Calabria on the knowledge of off-label drugs in pediatrics.

Francesca Saullo, Ernesto Saullo, Mimma Caloiero, Michele Menniti, Claudia Carbone, Serafina Chimirri, Laura Paletta, Luca Gallelli

Open access · greenAbstract read
In one paragraph

Article in Journal of pharmacology & pharmacotherapeutics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Francesca SaulloCentro Regionale di Informazione sul farmaco, AO Mater Domini, Catanzaro and Department of Health Science, School of Medicine, University of Catanzaro, Italy.
Ernesto SaulloUnità Operativa di Pediatria, Presidio Ospedaliero "Giovanni Paolo II" Lamezia Terme, Azienda Sanitaria di Catanzaro, Italy.
Mimma CaloieroUnità Operativa di Pediatria, Presidio Ospedaliero "Giovanni Paolo II" Lamezia Terme, Azienda Sanitaria di Catanzaro, Italy.
Michele MennitiCentro Regionale di Informazione sul farmaco, AO Mater Domini, Catanzaro and Department of Health Science, School of Medicine, University of Catanzaro, Italy.
Claudia CarboneCentro Regionale di Informazione sul farmaco, AO Mater Domini, Catanzaro and Department of Health Science, School of Medicine, University of Catanzaro, Italy.
Serafina ChimirriCentro Regionale di Informazione sul farmaco, AO Mater Domini, Catanzaro and Department of Health Science, School of Medicine, University of Catanzaro, Italy.
Laura PalettaCentro Regionale di Informazione sul farmaco, AO Mater Domini, Catanzaro and Department of Health Science, School of Medicine, University of Catanzaro, Italy.
Luca GallelliCentro Regionale di Informazione sul farmaco, AO Mater Domini, Catanzaro and Department of Health Science, School of Medicine, University of Catanzaro, Italy.
Presidio Ospedaliero · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Off-label use is very common among pediatricians, and the main cause is attributable to the lack of drugs specifically designed and marketed for children in different age groups. In this study, we evaluated, through a questionnaire, the knowledge of off-label drugs in pediatrics. Furthermore, we made a directory of 28 off-label drugs most commonly used by pediatricians in agreement with data obtained from Italian Agency for drugs (AIFA) referred to the law no. 648/1996; 180 pediatricians referred to the Italian Society of Pediatrics Calabrian section were asked to complete an online anonymous questionnaire. Eighty five (47.3%) of these completed the anonymous questionnaire, 40% revealed that they used off-label drugs "sometimes"; generally, drugs were used off-label for age and to treat respiratory diseases. For 75 pediatricians (88%) the information about the risk/benefit of off-label drugs is inadequate and 63 pediatricians (74%) did not have a good knowledge about this practice. In conclusion, the knowledge of off-label drugs is very low in pediatricians; more information about off-label drugs could be useful in order to improve the appropriateness of drugs' prescription and to reduce the development of side effects and improving drug safety.

Indexed as

Childrenoff-label drugspediatricsquestionnaire

Identifiers

PMID24347983
PMCPMC3853670
OpenAlexW1995142717

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.